• Exchange: NSX
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Price not available for IQN:AU

Snapshot for IQnovate Ltd (IQN)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for IQN

No chart data available.
  • IQN:AU
  • 1M
  • 1Y
Interactive IQN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IQN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 0.00
Shares Outstanding (M) 37.46
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IQN

No data available

Company Profile & Key Executives for IQN

Iqnovate Ltd. is a global contract medical organisation and scientific service provider to the Biopharmaceutical industry. The Company also provides advisory services to institutional capital investors on biotech investment strategies. Iqnovate focuses on every segment of the drug life cycle, from preclinical-clinical, through to RRC, bridging science with business.

George SyrmalisChairman/CEOCon TsigounisExecutive Director
Spiro SakirisSecretary
More Company Profile & Key Executives for IQN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil